NCT04145661

Brief Summary

The investigators are interested in an additional hearing aid feature called non-linear frequency compression (NLFC). This aims to improve audibility of high frequency sounds by converting them into lower frequencies and has been shown to benefit those with moderate-severe sensorineural hearing loss (SNHL). Cochlear dead regions (DRs) are areas of the inner hearing organ (the cochlea) where there is little or no function and are commonly found in regions responsible for detecting high pitched (frequency) sounds. Not all people with hearing loss have DRs. The investigators would like to determine whether based on the presence or absence of DRs, patients with moderate-severe SNHL perform better or prefer their hearing aids programmed conventionally, or with NLFC activated. To do this, two participant groups will be created based on findings from the threshold equalising noise (TEN) test which identifies cochlear DRs. Two participant groups will be created; one group with DRs and one group without DRs. All participants will receive two hearing aids and will wear these programmed conventionally for \~six weeks and with NLFC activated for \~six weeks in a counterbalanced manner. Following each condition, participants will complete a questionnaire and various speech tests will be performed. This involves participants repeating sentences, words or speech sounds they hear from a speaker in quiet and in the presence of background noise. Individuals' scores will be calculated for each test and their performance when NLFC was activated and deactivated will be compared. This will be analysed alongside the questionnaire data to compare the 'DR' and 'no DR' group in both conditions. Findings may help to determine whether NLFC should be activated for all moderate-severe SNHL patients, or just those with DRs, helping clinicians to optimise hearing aid settings for patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 30, 2019

Completed
21 days until next milestone

Study Start

First participant enrolled

November 20, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 26, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 26, 2020

Completed
Last Updated

June 1, 2020

Status Verified

May 1, 2020

Enrollment Period

4 months

First QC Date

October 29, 2019

Last Update Submit

May 28, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Bamford-Kowal-Bench (BKB) English-language sentences

    BKB is a standard sentence list comprised of three or four key words per sentence. The adaptive BKB sentence test requires the noise to be presented at 55 A- weighted decibels (dBA) and the speech level adapts depending on whether the participant repeats the sentence correctly or not. Participants will be given a score in dB which corresponds to the intensity level at which 71% of the sentences are correctly identified. One sentence list will each be administered when the noise is presented at 0°, +90° and -90° and an average overall score in dB will be calculated. The lower the score in dB, the better the participant has performed.

    Six weeks following the programming of each of the two hearing aid setting.

  • Arthur Boothroyd (AB) word list

    The AB word list aims to assess patient's speech discrimination ability, awarding one point for each phoneme repeated correctly in each word. Words will be presented from a loudspeaker at 65 decibels sound pressure level (dB SPL) in the absence of background noise. All words are monosyllabic and comprised of three phonemes, one mark is awarded for each correct phoneme (0,1,2,3). A single list contains ten words, giving a total of 30 phonemes per list. For each test session, three different word lists will be used and the number of phonemes correctly repeated will be recorded, allowing participant's scores out of 90 to be calculated. The greater the score, the better the performance.

    Six weeks following the programming of each of the two hearing aid setting.

  • Auditory speech sounds evaluation (ASSE).

    ASSE is a psychoacoustic test that directly assesses participant's ability to discriminate between different phonemes. ASSE discrimination is an oddity test aiming to assess supra threshold performance. At a level of 70dB SPL, following three to eight presentations of a single speech sound, a different speech sound will be played, and participants should respond to the 'odd one out'. If participants respond correctly to two out of three presentations, it can be concluded that the contrast between the background phoneme and the odd speech sound is well discriminated and this will be marked as correct. Seven pairs will be used that include both high and low frequency containing phonemes. Participants will be given a percentage score based on how many of the seven speech pairs they are successfully able to discriminate between. The higher the percentage, the better able the participant is to discriminate.

    Six weeks following the programming of each of the two hearing aid setting.

  • The SSQ12 questionnaire.

    A validated shortened version of the speech, spatial and qualities of hearing scale (SSQ) questionnaire. The questionnaire will be administered during sessions three and four to compare patient's experiences with NLFC and CP. This will be carried out in an interview style format to ensure participants understand the questions. Participant's scores out of 120 will be calculated and compared in the two conditions. The higher the score, the better the patient finds the hearing aids.

    Six weeks following the programming of each of the two hearing aid setting.

Study Arms (2)

DR group

EXPERIMENTAL

Participants who have cochlear dead regions, identified by the thresholds equalising noise test will be placed in this group.

Device: Hearing aids programmed conventionally.Device: Hearing aids programmed with compression activated.

No DR group

EXPERIMENTAL

Participants who have no cochlear dead regions, identified by the thresholds equalising noise test will be placed in this group.

Device: Hearing aids programmed conventionally.Device: Hearing aids programmed with compression activated.

Interventions

All participants will wear their hearing aids programmed in this way for around six weeks.

DR groupNo DR group

All participants will wear their hearing aids programmed in this way for around six weeks.

DR groupNo DR group

Eligibility Criteria

Age44 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 45 years and above.
  • Bilateral moderate to severe symmetrical sensorineural hearing loss, defined as PTA thresholds from 0.5- 4kHz falling between 40dB and 85dB.
  • Normal otoscopic examination and normal middle ear function.
  • Currently wears bilateral hearing aids.
  • Good hearing aid user \>5 hours a day bilaterally, assessed by data logging.
  • English as a first language, due to the speech testing material

You may not qualify if:

  • Under 45 years old
  • Asymmetrical, mixed or conductive hearing loss,
  • Recent history (\<1 year) of otalgia, otitis externa, otitis media with effusion.
  • Current or recent (\<12 months ago) exposure to ototoxic medication e.g. cisplatin (or other platinum-containing chemotherapy drugs) or amikacin (or other aminoglycoside antibiotics), as stable hearing thresholds are required for the duration of the study.
  • Poor hearing aid user with data logging \<5 hours a day.
  • English as a foreign language, illiterate or unable to read due to poor eyesight.
  • Diagnosis of conditions such as muscular dystrophies or chronic fatigue syndrome that may cause tiring during testing.
  • Diagnosis of dementia or a neurological condition that would suggest poor cognitive function.
  • Identification of a significant cochlear dead region (\< 3kHz) in one ear only.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manchester University NHS Foundation Trust

Manchester, M13 9WU, United Kingdom

Location

Related Publications (7)

  • Salorio-Corbetto M, Baer T, Moore BCJ. Comparison of Frequency Transposition and Frequency Compression for People With Extensive Dead Regions in the Cochlea. Trends Hear. 2019 Jan-Dec;23:2331216518822206. doi: 10.1177/2331216518822206.

    PMID: 30803386BACKGROUND
  • Vinay, Moore BC. Prevalence of dead regions in subjects with sensorineural hearing loss. Ear Hear. 2007 Apr;28(2):231-41. doi: 10.1097/AUD.0b013e31803126e2.

    PMID: 17496673BACKGROUND
  • Salorio-Corbetto M, Baer T, Moore BC. Quality ratings of frequency-compressed speech by participants with extensive high-frequency dead regions in the cochlea. Int J Audiol. 2017 Feb;56(2):106-120. doi: 10.1080/14992027.2016.1234071. Epub 2016 Oct 11.

    PMID: 27724057BACKGROUND
  • Salorio-Corbetto M, Baer T, Moore BCJ. Evaluation of a Frequency-Lowering Algorithm for Adults With High-Frequency Hearing Loss. Trends Hear. 2017 Jan-Dec;21:2331216517734455. doi: 10.1177/2331216517734455.

    PMID: 29027511BACKGROUND
  • Pepler A, Munro KJ, Lewis K, Kluk K. Prevalence of cochlear dead regions in new referrals and existing adult hearing aid users. Ear Hear. 2014 May-Jun;35(3):e99-e109. doi: 10.1097/AUD.0000000000000011.

    PMID: 24496291BACKGROUND
  • Glista D, Scollie S, Bagatto M, Seewald R, Parsa V, Johnson A. Evaluation of nonlinear frequency compression: clinical outcomes. Int J Audiol. 2009;48(9):632-44. doi: 10.1080/14992020902971349.

    PMID: 19504379BACKGROUND
  • Ellis RJ, Munro KJ. Benefit from, and acclimatization to, frequency compression hearing aids in experienced adult hearing-aid users. Int J Audiol. 2015 Jan;54(1):37-47. doi: 10.3109/14992027.2014.948217. Epub 2014 Dec 3.

    PMID: 25470620BACKGROUND

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Melissa Handford

    Manchester University NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will not be aware of the type of hearing aid setting they are experiencing. All participants will experience both .
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants will be split into two groups depending on whether or not they have 'cochlear dead regions'. All participants will experience both conventional processing and frequency compression for six weeks. The order of which will be randomised and counterbalanced between groups.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2019

First Posted

October 30, 2019

Study Start

November 20, 2019

Primary Completion

March 26, 2020

Study Completion

March 26, 2020

Last Updated

June 1, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

This is a Masters Dissertation project. All data will be anonymised at the first available opportunity.

Locations